Drug intelligence / Profile preview

carprofen

Development stage
Unknown
Lead developer
Zoetis
Modality
Small Molecules
Administration
Oral, Subcutaneous, Intravenous
01

Overview

Carprofen is a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid and carbazole class, structurally related to ibuprofen, naproxen, and ketoprofen. It was previously used in human medicine but is now approved only for veterinary use, primarily in dogs. Carprofen is indicated for the relief of pain and inflammation associated with osteoarthritis and postoperative pain in dogs. Its mechanism of action involves selective inhibition of cyclooxygenase-2 (COX-2) over cyclooxygenase-1 (COX-1), reducing prostaglandin synthesis involved in inflammation while minimizing gastrointestinal side effects typical of less selective NSAIDs. Carprofen has analgesic, anti-inflammatory, and antipyretic properties[1][2][4][7].

Brand names
Rimadyl
Other names
6-chloro-alpha-methyl-9H-carbazole-2-acetic acidcarprofen
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)UGT2B7 (UDP-glucuronosyltransferase 2B7)

Beyond the preview

Go deeper on carprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carprofen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call